Long-term outcome of bicuspid aortic valve disease
European Heart Journal - Cardiovascular Imaging · 22.02.2024 · 25 (3) · 425-435
DOI: 10.1093/ehjci/jead312 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, online erschienen am 15.11.2023. Verfasst von Julia Aschauer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria. Hauptthemen laut MEDLINE: Bicuspid Aortic Valve Disease, Heart Valve Diseases, Aortic Valve Stenosis, Aortic Valve Insufficiency. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Bicuspid aortic valve (BAV) is a common congenital condition that is frequently associated with aortic stenosis (AS) and aortic regurgitation (AR), as well as aortic aneurysms, but specific outcome data are scarce. The present study sought to assess outcomes in a large cohort of consecutive patients with BAV. Methods and results A total of 581 consecutive patients (median age 29 years, 157 female) with BAV were included in the study and followed prospectively in a heart valve clinic follow-up programme. The overall survival rate after 10 years was 94.5%. During follow-up, 158 patients developed an indication for surgery. Event-free survival rates were 97%, 94%, 87%, and 73% at 1, 2, 5, and 10 years, respectively. In the multivariable analysis, event rates were independently predicted by AS [subdistribution hazard ratio (SHR) 2.3 per degree of severity], AR (SHR 1.5 per degree of severity), baseline aortic dilatation ≥ 40 mm (SHR 1.9), and age (SHR 1.3) (P < 0.001).
Conclusion
BAV disease is associated with a high rate of cardiac events, but state-of-the-art care results in good survival with low rates of infective endocarditis, aortic dissection, and sudden death. Incremental degrees of AS and regurgitation, the presence of aortic dilatation, and age are predictive of cardiac events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria.
- Center for Medical Data Science, Institute of Clinical Biometrics, Medical University of Vienna, Vienna, Austria.
- Institute of Cardiology, Catholic University of Sacred Heart, Rome, Italy.
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Robert Zilberszac, Raphael Rosenhek
Zitieren
APA
Aschauer, J., Zilberszac, R., Gleiss, A., Colizzi, C., Binder, T., Bruno, P., Laufer, G., Massetti, M., Gabriel, H., & Rosenhek, R. (2024). Long-term outcome of bicuspid aortic valve disease. European Heart Journal - Cardiovascular Imaging, 25(3), 425-435. https://doi.org/10.1093/ehjci/jead312
Vancouver
Aschauer J, Zilberszac R, Gleiss A, Colizzi C, Binder T, Bruno P, et al. Long-term outcome of bicuspid aortic valve disease. European Heart Journal - Cardiovascular Imaging. 2024;25(3):425-435. doi:10.1093/ehjci/jead312
BibTeX
@article{Aschauer2024,
author = {Aschauer, Julia and Zilberszac, Robert and Gleiss, Andreas and Colizzi, Christian and Binder, Thomas and Bruno, Piergiorgio and Laufer, Günther and Massetti, Massimo and Gabriel, Harald and Rosenhek, Raphael},
title = {Long-term outcome of bicuspid aortic valve disease},
journal = {European Heart Journal - Cardiovascular Imaging},
year = {2024},
volume = {25},
number = {3},
pages = {425--435},
doi = {10.1093/ehjci/jead312}
}
EUVIMED